This site is intended for healthcare professionals
Antiplatelet therapy in ACS: Choices and Controversies


Read time: 60 mins
Last updated:17th Dec 2021
Published:17th Dec 2021

Acute coronary syndrome (ACS) represents a leading cause of mortality and morbidity worldwide. Antiplatelet therapy is a cornerstone of ACS management.

  • The current available antiplatelet therapies for patients with ACS
  • The challenges in antiplatelet therapy selection
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest